Chloropyrazine → HCID 52919897, compound
Reaction equation
[CH2:1]([CH:8]1[NH:13][CH2:12][CH2:11][N:10]([C:14]2[CH:22]=[C:21]3[C:17]([C:18]([CH2:26][CH3:27])=[N:19][N:20]3[CH:23]([CH3:25])[CH3:24])=[CH:16][CH:15]=2)[CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Cl[C:29]1[CH:34]=[N:33][CH:32]=[CH:31][N:30]=1>>[CH2:1]([C@@H:8]1[N:13]([C:29]2[CH:34]=[N:33][CH:32]=[CH:31][N:30]=2)[CH2:12][CH2:11][N:10]([C:14]2[CH:22]=[C:21]3[C:17]([C:18]([CH2:26][CH3:27])=[N:19][N:20]3[CH:23]([CH3:24])[CH3:25])=[CH:16][CH:15]=2)[CH2:9]1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
3
Procedure
Prepared using the same procedure described in Example 410 from 6-(3-benzyl-piperazin-1-yl)-3-ethyl-1-isopropyl-1H-indazole and chloropyrazine to afford the title compound as a yellow solid (7 mg, 12%). LC/MS (Method B) 4.47 min, [M+1]+ 441.
Workup
- customPrepared
Sources & evidence
- ORD record
- ord-fa8451b6bc3d419fb78961017c2f492a
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08927546B2
Reaction notes
Loading…